Decreased energy reserve in an animal model of dilated cardiomyopathy: Relationship to contractile performance

Circulation Research

Volumn 78, Issue 5, 1996, Pages 893-902

  Liao, Ronglih ^a,b   Nascimben, Luigino ^c   Friedrich, Jan ^c   Gwathmey, Judith K ^a,b   Ingwall, Joanne S ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

31P nuclear magnetic resonance magnetization transfer; cardiac performance; cardiomyopathy; creatine kinase; phosphocreatine

Indexed keywords

CREATINE KINASE; CREATINE PHOSPHATE;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; COMPETITIVE INHIBITION; HEART DILATATION; HEART LEFT VENTRICLE WORK; HEART MUSCLE CONTRACTILE FORCE; HEART PERFORMANCE; ISOLATED HEART; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; TURKEY (BIRD);

EID: 0030010439     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.5.893     Document Type: Article

References (48)

1. Bittl JA, Ingwall JS. Reaction rates of CK and ATP synthesis in the isolated rat heart. J Biol Chem. 1985;260:3512-3517.
2. Zimmer H-G, Trendelenburg C, Kammermeier H, Gerlach E. De novo synthesis of myocardial adenine nucleotides in the isolated perfused rat heart. Circ Res. 1973;32:635-642.
3. 31P-NMR surface coil studies m living rat. Circ Res. 1987;60:871-878.
4. 31P-NMR magnetization transfer study of the isolated ferret heart. Circ Res. 1988;63:1-15.
5. -NMR studies in the isolated blood perfusion rat heart. Circulation. 1993;88(suppl I):I-43. Abstract.
6. Fossel ET, Hoefeler H. Complete inhibition of creatine kinase in isolated perfused rat hearts. Am J Physiol. 1987;252(Endocrinol Metab 15):E124-E130.
7. Hamman BL, Bittl JA, Jacobus WE, Allen PD, Spencer RS, Tian R, Ingwall JS. Inhibition of the creatine kinase reaction decreases the contractile reserve of the isolated rat heart. Am J Physiol. 1996;269(Heart Circ Physiol 38):H1030-H1036.
8. Chevli R, Fitch CD. β-Guanidinopropionate and phosphorylated β-guanidinopropionate as substrates for creatine kinase. Biochem Med. 1979;21:162-167.
9. Shoubridge EA, Jeffry FMH, Keogh JM, Radda GK, Seymour AML. CK kinetics, ATP turnover and cardiac performance in hearts depleted of creatine with the substrate analog β-guanidinopropionic acid. Biochim Biophys Acta. 1985;847:25-32.
10. Kapelko VI, Kupriyanov VV, Novikova NA, Lakomkin VL, Steinschneider AY, Severina MY, Veksler VI, Saks VA. The cardiac contractile failure induced by chronic creatine and phosphocreatine deficiency. J Mol Cell Cardiol. 1988;20:465-479.
11. Zweier JL, Jacobus WE, Korecky B, Brandejs-Barry Y. Bioenergetic consequences of cardiac phosphocreatine depletion induced by creatine analogue feeding. J Biol Chem. 1991;266: 20296-20304.
12. van Deurson J, Heerschap A, Oerlemans F, Ruitenbeek W, Jap P, ter Laak H, Wieringa B. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell. 1993;74:621-631.
13. Nascimben L, Friedrich J, Liao R, Pauletto P, Pessina AC, Ingwall JS. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation. 1995; 91:1824-1833.
14. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation. 1993;87(suppl VII):VII-58-VII-62.
15. Sylven C, Lin L, Jansson E, Sotonyi P, Fu L-X, Waagstein F, Hjalmarsson A, Marcus C, Bronnegard M. Ventricular adenine nucleotide translocator mRNA is upregulated in dilated cardiomyopathy. Cardiovasc Res. 1993;27:1295-1299.
16. 31P magnetic resonance spectroscopy using the rotating frame-depth selection technique. Ann N Y Acad Sci. 1987;508:321-332.
17. 31P magnetic resonance spectroscopy. Lancet. 1991;338:973-976.
18. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J. 1991;122:795-801.
19. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered high-energy phosphate metabolism in heart failure. Circulation. 1992;86:1810-1818.
20. 31P nuclear magnetic resonance spectroscopy in patients with old myocardial infarction. Jpn Circ J. 1992;56:614-619.
21. Neubauer S, Horn M, Naumann A, Tian R, Hu K, Laser M, Friedrich J, Gaudron P, Schnackerz K, Ingwall JS, Ertl G. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest. 1995;95:1092-1100.
22. Fitch CD, Shields RP, Payne WF, Dacus JM. Creatine metabolism in skeletal muscle, III: specificity of the creatine entry process. J Biol Chem. 1968;243:2024-2027.
23. Jankus EF, Noren GR, Staley NA. Research note-furazolidone-induced cardiac dilation in turkeys. Avion Dis. 1972;16:958-961.
24. Gwathmey JK. Morphological changes associated with furazolidone-induced cardiomyopathy: effects of digoxin and propranolol. J Comp Pathol. 1991;104:33-45.
25. Hajjar RJ, Liao R, Young JB, Fuleihan F, Glass MG, Gwathmey JK. Pathophysiological and biochemical characterization of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy. Cardiovasc Res. 1993;27:2212-2221.
26. Gruver EJ, Glass MG, Marsh JD, Gwathmey JK. An animal model of dilated cardiomyopathy: characterization of dihydropyridine receptors and contractile performance. Am J Physiol. 1993; 265(Heart Circ Physiol 34):H1704-H1711.
27. 2+ channel antagonists in an animal model of dilated cardiomyopathy: effect on gross morphology, global cardiac function, and twitch force. Circ Res. 1993; 73:1077-1089.
28. Neely JR, Libermeister H, Battersby EJ, Morgan HE. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol. 1967;212:804-815.
29. McLeod K, Comisarow MB. Systematic errors in the discrete integration of Fourier transform nuclear magnetic resonance spectra. J Magn Reson Imaging. 1989;84:490-500.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193: 265-275.
31. Kammermeier H. Microassay of free and total creatine from tissue extracts by combination of chromatographic and fluorometric methods. Anal Biochem. 1973;56:341-345.
32. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 1967;69:696-705.
33. Bak MI, Ingwall JS. NMR-invisible ATP in heart: fact or fiction? Am J Physiol. 1992;262(Endocrinol Metab 25):E943-E947.
34. 31P NMR spectroscopy and phosphate markers. Magn Reson Med. 1994;32:181-188.
35. Polimeni PI. Measurement of myocardial electrolyte distributions. Tech Life Sci Cardiovasc Physiol. 1984;317:1-34.
36. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats: infarct size, myocyte hypertrophy, and capillary growth. Circ Res. 1986;58:26-37.
37. 1 measurements with and without exchange in the heart. Magn Reson Med. 1993;30:45-50.
38. Veech RL, Lawson JWR, Cornell NW, Krebs HA. Cytosolic phosphorylation potential. J Biol Chem. 1979;254:6538-6547.
39. Forsen S, Hoffman RA. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys. 1963;39:2892-2901.
40. Takaoka H, Takeuchi M, Odake M, Hayashi Y, Hata K, Mori M, Yokoyama M. Comparison of hemodynamic determinants for myocardial oxygen consumption under different contractile states in human ventricle. Circulation. 1993;87:59-69.
41. Tian R, Gaudron P, Neubauer S, Hu K, Ertl G. Alterations of performance and oxygen utilization in chronically infarcted rat hearts. J Mol Cell Cardiol. 1996;28:321-330.
42. Tian R, Nascimben L, Kaddurah-Daouk R, Ingwall JS. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol. In press.
43. Bittl JA, Ingwall JS. Intracellular high-energy phosphate transfer in normal and hypertrophied myocardium. Circulation. 1987;75(suppl I):I-96. Abstract.
44. 31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart. Circulation. 1995;92:3527-3538.
45. Mirsalimi SM, Qureshi FS, Julian RJ, O'Brien PJ. Myocardial biochemical changes in furazolidone-induced cardiomyopathy of turkeys. J Comp Pathol. 1990;102:139-147.
46. Nascimben L, Tian R, Lorell BH, Reis I, Weinberg EO, Ingwall JS. Rates of insulin-independent glucose entry and glycolysis are increased in hypertrophied hearts. Circulation. 1995;92(suppl I):I-770. Abstract.
47. Nascimben L, Pauletto P, Pessina AC, Reis I, Ingwall JS. Decreased energy reserve may cause pump failure in human dilated cardiomyopathy. Circulation. 1991;84(suppl II):II-563. Abstract.
48. Bottomley PA, Herfkens RJ, Smith LS, Bashore TM. Altered phosphate metabolism in myocardial infarction: P-31 NMR spectroscopy. Radiology. 1987;165:703-707.